Table S2. A. 70 Prognostic Germline Variants Identified in Analyis 1. B. Five Prognostic Germline Variants Identified in Analysis 2. C. 103 Prognostic Germline Variants Identified in Analysis 3. D. 9
Breast cancer recurrence (BCR) is a common treatment outcome despite curative-intent primary treatment of non-metastatic breast cancer. Currently used prognostic and predictive factors utilize tumor-b
Supplemental table 1. Summary of the overlapped region between AVENIO ctDNA expanded kit targeted genomic region and Sec-seq V-tracking system targeted genomic region.
